Mesa Laboratories, Inc.
MLAB · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $27 | $28 | $33 | $49 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $42 | $39 | $43 | $41 |
| Inventory | $25 | $33 | $35 | $25 |
| Other Curr. Assets | $8 | $9 | $9 | $9 |
| Total Curr. Assets | $103 | $109 | $119 | $124 |
| Property Plant & Equip (Net) | $32 | $41 | $28 | $29 |
| Goodwill | $182 | $180 | $286 | $291 |
| Intangibles | $97 | $114 | $217 | $250 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $1 | $1 | $1 | $1 |
| Other NC Assets | $18 | $1 | $10 | $12 |
| Total NC Assets | $331 | $337 | $543 | $583 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $433 | $447 | $662 | $707 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $6 | $8 |
| Short-Term Debt | $105 | $3 | $3 | $3 |
| Tax Payable | $11 | $2 | $9 | $8 |
| Deferred Revenue | $15 | $15 | $16 | $15 |
| Other Curr. Liab. | $28 | $18 | $10 | $15 |
| Total Curr. Liab. | $164 | $44 | $43 | $48 |
| LT Debt | $77 | $228 | $183 | $218 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $20 | $20 | $34 | $39 |
| Other NC Liab. | $12 | $9 | $8 | $8 |
| Total NC Liab. | $110 | $257 | $225 | $266 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $10 | $3 | $3 |
| Total Liabilities | $274 | $301 | $268 | $314 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $359 | $344 | $332 | $313 |
| Retained Earnings | -$189 | -$183 | $74 | $77 |
| AOCI | -$10 | -$15 | -$13 | $4 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $160 | $145 | $393 | $394 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $433 | $447 | $662 | $707 |
| Net Debt | $154 | $203 | $153 | $172 |